Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis

Published:2022-02 Issue:2 Volume:97 Page:308-324
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Riaz Irbaz Bin^ORCID,Fuentes Harry E.^ORCID,Naqvi Syed Arsalan Ahmed^ORCID,He Huan,Sipra Qurat-ul-Ain Riaz,Tafur Alfonso J.,Padranos Leslie,Wysokinski Waldemar E.^ORCID,Marshall Ariela L.^ORCID,Vandvik Per Olav,Montori Victor^ORCID,Bryce Alan H.,Liu Hongfang,Badgett Robert G.^ORCID,Murad Mohammad Hassan^ORCID,McBane Robert D.^ORCID

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

General Medicine

Reference54 articles.

1. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer;Lee;N Engl J Med,2003

2. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: the ADAM VTE trial;McBane;J Thromb Haemost,2020

3. Anticoagulant therapy for venous thromboembolism in cancer;Lee;N Engl J Med,2020

4. Apixaban for the treatment of venous thromboembolism associated with cancer;Agnelli;N Engl J Med,2020

5. Edoxaban for the treatment of cancer-associated venous thromboembolism;Raskob;N Engl J Med,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023);Clinical and Translational Oncology;2024-08-07

2. Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2;Thrombosis and Haemostasis;2024-04-29

3. Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment. A review;Journal of Modern Oncology;2024-03-05

4. Anticoagulation in venous thromboembolism for the general physician;Journal of the Royal College of Physicians of Edinburgh;2024-03

5. The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study;Thrombosis Research;2024-03